Example: Heart Attack
Search clinical trials for: Reishi
Total 3 results
-
NCT03589781WithdrawnConditions: Prostate Cancer
-
NCT02909686Active, not recruitingConditions: Gulf War Illness
-
NCT02486796TerminatedConditions: Quality of Life
We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
Medical Conditions
- COVID-19
- Atrophy, Geographic
- Biotinidase Deficiency
- CHD Risk-Equivalent Disease
- Coffee With or Without Caffeine
- Cytokine Storm (Covid-19)
- MSI Positive Colorectal Cancer
- Non-inflammatory Degenerative Joint Disease (NIDJD) of the Knee
- Painful Bone Metastases
- Postmenopausal Women Osteoporosis
- Pulse Oximeter Calibration
- Recurrent Anaplastic Large Cell Lymphoma
- Recurrent Calcic Urolithiasis
- Thrombosis of Portal Venous System.
- View Full List
Sponsors and Collaborators
- Beijing Zhong Sheng Heng Yi Pharmaceutical Technology Co., Ltd.
- Coastal Carolina Radiation Oncology
- Gottfries Clinic AB
- International Centre for Behavioural Studies
- MonitorCRO
- Moscow city hospital named after S.I. Spasokukotskiy
- Naval Medical Center Camp Lejeune
- Pacific NW Dental Practice-Based Research Network
- Prof. Claudio Bassetti
- Spina, Stefano, M.D., Massachusetts General Hospital
- The Airport Hospital of Shunyi District Beijing
- US Army Medical Research Directorate-Africa - Walter Reed Army Institute of Research
- Zsolt Molnár, MD, PhD, DEAA
- View Full List
Drug Interventions
- BoNT-A injection
- Daikenchuto (TU-100)
- Dexmedetomidine Hcl infusion
- Gemcitabine and Capecitabine and Avastin
- HES 130/0.42 + electrolyte solution
- Interferon beta-1b/Atorvastatin group
- JNJ-42847922 5 mg
- MDX-010
- Paritaprevir
- Psyllium Orange
- Rhinoebastel
- alpha lipoic acid drug (thioctic acid acid)
- suvorexant
- View Full List
Conditions
Rare Diseases
Drug Interventions
Dietary Supplements
Sponsor/Collaborators
Locations